3′,4′‐Bis(4‐chloro­phenyl)­spiro­[chroman‐3,5′(4′H)‐isoxazol]‐4‐one

The title compound, C₂₃H₁₅Cl₂NO₃, crystallizes with two independent mol­ecules in the asymmetric unit. The chroman­one moiety consists of a benzene ring fused with a six‐membered heterocyclic ring which adopts a sofa conformation. The five‐membered spiro­isoxazoline ring is in an envelope conformation. The p‐chloro­phenyl rings bridged by the five‐membered ring are nearly perpendicular to each other. The chromanone moiety of one mol­ecule packs into the cavity formed by the p‐chloro­phenyl rings of a second mol­ecule through the formation of C—H?π interactions. The structure is stabilized by weak C—H?O, C—H?Cl and C—H?π interactions.     

5‐Methyl‐6‐aza‐2′‐deoxy­isocytidine

In the title compound, 3‐amino‐2‐(2‐deoxy‐β‐d ‐erythro‐pento­furan­osyl)‐6‐methyl‐1,2,4‐triazin‐5(2H)‐one, C₉H₁₄N₄O₄, the conformation of the N‐glycosidic bond is high‐anti and the 2‐deoxy­ribo­furan­osyl moiety adopts a North sugar pucker (²T₃). The orientation of the exocyclic C—C bond between the –CH₂OH group and the five‐membered ring is ap (gauche, trans). The crystal packing is such that the nucleobases lie parallel to the ac plane; the planes are connected via hydrogen bonds involving the five‐membered ring.     

2,2′‐Anhydro‐1‐(3′,5′‐di‐O‐acetyl‐β‐D‐arabinofuranosyl)uracil,a cyclouridine nucleoside with a C4′‐endo furanosyl conformation

2,2′‐Anhydro‐1‐(3′,5′‐di‐O‐acetyl‐β‐D‐arabinofuranosyl)uracil, C₁₃H₁₄N₂O₇, was obtained by refluxing 2′,3′‐O‐(methoxymethylene)uridine in acetic anhydride. The structure exhibits a nearly perfect C4′‐endo (⁴E) conformation. The best four‐atom plane of the five‐membered furanose ring is O—C—C—C, involving the C atoms of the fused five‐membered oxazolidine ring, and the torsion angle is only −0.4 (2)°. The oxazolidine ring is essentially coplanar with the six‐membered uracil ring [r.m.s. deviation = 0.012 (5) Å and dihedral angle = −3.2 (3)°]. The conformation at the exocyclic C—C bond is gauche–trans which is stabilized by various C—H...π and C—O...π interactions.     

Ethyl 6‐acetylamino‐6,7‐dihydro‐5H‐dibenzo[a,c]cycloheptene‐6‐carboxylate

The title compound, C₂₀H₂₁NO₃, is a derivative of Aib (α‐­aminoisobutyric acid) and is cyclized at the C^α position by bi­phenyl rings. The seven‐membered ring possesses C2 symmetry. The C^α cyclization causes the backbone to assume a helical conformation in the crystal structure. The packing of the mol­ecules is stabilized by intermolecular C—H?O, C—H?π and N—H?O hydrogen bonds.     

(S,S)‐4′′‐Cyano‐7,7′′‐dimethoxy‐3′,6′‐dioxodispiro[indane‐2,2′‐piperazine‐5′,2′′‐indane]‐4‐carboxamide methanol solvate: interrupting the amide‐to‐amide hydrogen‐bonded tape

The title methanol solvate, C₂₄H₂₂N₄O₅·CH₃OH, forms an extended three‐dimensional hydrogen‐bonded structure, assisted by the presence of several good donor and acceptor sites. It shows none of the crystal packing features typically expected of piperazinediones, such as amide‐to‐amide R₂²(8) hydrogen bonding. In this structure the methanol solvent appears to play only a space‐filling role; it is not involved in any hydrogen bonding and instead is disordered over several sites. This study reports, to the best of our knowledge, the first crystal structure of an indane‐containing piperazinedione compound which exhibits a three‐dimensional hydrogen‐bonded structure formed by classical (N—H...O and N—H...N) hydrogen‐bonding interactions.     

17‐Oxo‐16‐(2‐pyridyl­methyl­ene)­androst‐5‐en‐3β‐ol monohydrate

The title compound, C₂₅H₃₁NO₂·H₂O, has the outer two six‐membered rings in chair conformations, while the central ring is in an 8β,9α‐half‐chair conformation. The five‐membered ring adopts a 13,14‐half‐chair conformation. The pyridyl­methyl­ene moiety has an E configuration with respect to the carbonyl group at position 17. The structure is stabilized by intermolecular O—H?N and O—H?O hydrogen bonds.     

(1R,3S)‐Camphoramic acid

The title chiral compound, 3‐amino­carbonyl‐1,2,2‐tri­methyl­cyclo­pentane‐1‐carboxylic acid, C₁₀H₁₇NO₃, was prepared from (1R,3S)‐camphoric acid. The five‐membered ring adopts a conformation which is intermediate between a twist and an envelope. Elongations of the C—C bonds and contractions of the C—C—C bond angles are observed within the five‐membered ring. A ¹H NMR spectrum was recorded to assist in distinguishing the amide group from the carboxyl group.     

Two isomeric 2‐[4‐chloro‐2‐fluoro‐5‐(prop‐2‐ynyloxy)phenyl]hexahydro­isoindole‐1,3‐dione compounds

The molecular structures of 2‐[4‐chloro‐2‐fluoro‐5‐(prop‐2‐ynyloxy)phenyl]‐1,3,4,5,6,7‐hexahydro­isoindole‐1,3‐dione, C₁₇H₁₃ClFNO₃, (I), and the isomeric compound 2‐[4‐chloro‐2‐fluoro‐5‐(prop‐2‐ynyloxy)phenyl]‐cis‐1,3,3a,4,7,7a‐hexahydro­isoindole‐1,3‐dione, (II), are, as anticipated, significantly different in their conformations and in the distances between the farthest two atoms. The six‐membered ring of the 1,3,4,5,6,7‐hexahydro­isoindole‐1,3‐dione moiety in (I) adopts a half‐chair conformation. The dihedral angle between the five‐membered dione ring of (I) and the benzene ring is 50.96 (7)°. The six‐membered ring of the cis‐1,3,3a,4,7,7a‐hexahydro­isoindole‐1,3‐dione moiety in (II) adopts a boat conformation. The dihedral angle in (II) between the five‐membered dione ring and the benzene ring is 61.03 (13)°. In the crystal structures, the molecules are linked by C—H⋯O hydrogen bonds and weak π–π interactions. Compound (I) is a much more potent herbicide than (II). The Cl⋯H distances between the farthest two atoms in (I) and (II) are 11.37 and 9.97 Å, respectively.     

3‐(p‐Chloro­phenyl)‐4‐phenyl‐4,5‐di­hydro­isoxazole‐5‐spiro‐2′‐1′,2′,3′,4′‐tetra­hydro­naphthalen‐1′‐one

In the title compound, C₂₄H₁₈ClNO₂, the phenyl ring and the tetralone moiety are approximately orthogonal to the isoxazoline ring. The isoxazoline ring adopts an envelope conformation, while the cyclo­hexenone ring of the tetralone moiety has an intermediate sofa/half‐chair conformation. In this structure, one C—H?N intermolecular and two C—H?O intramolecular hydrogen bonds occur; the H?A distances are 2.60, and 2.35 and 2.57 Å, respectively. The mol­ecules are held together by an intermolecular C—H?N hydrogen bond, forming a one‐dimensional chain along the [100] direction.     

2,3:4,6‐Di‐O‐isopropylidene‐α‐l‐sorbofuranose and 2,3‐O‐isopropylidene‐α‐l‐sorbofuranose

In the title compounds, C₁₂H₂₀O₆, (I), and C₉H₁₆O₆, (II), the five‐membered furanose ring adopts a ⁴T₃ conformation and the five‐membered 1,3‐dioxolane ring adopts an E₃ conformation. The six‐membered 1,3‐dioxane ring in (I) adopts an almost ideal ^OC₃ conformation. The hydrogen‐bonding patterns for these compounds differ substantially: (I) features just one intramolecular O—H...O hydrogen bond [O...O = 2.933 (3) Å], whereas (II) exhibits, apart from the corresponding intramolecular O—H...O hydrogen bond [O...O = 2.7638 (13) Å], two intermolecular bonds of this type [O...O = 2.7708 (13) and 2.7730 (12) Å]. This study illustrates both the similarity between the conformations of furanose, 1,3‐dioxolane and 1,3‐dioxane rings in analogous isopropylidene‐substituted carbohydrate structures and the only negligible influence of the presence of a 1,3‐dioxane ring on the conformations of furanose and 1,3‐dioxolane rings. In addition, in comparison with reported analogs, replacement of the –CH₂OH group at the C1‐furanose position by another group can considerably affect the conformation of the 1,3‐dioxolane ring.     

The first structurally analysed nucleic acid building block containing the Reese protecting group: 2′‐O‐[1‐(2‐fluorophenyl)‐4‐methoxypiperidin‐4‐yl]‐β‐D‐(1′R,2′R,3′R,4′R)‐uridine

The title compound, C₂₁H₂₆FN₃O₇, is assembled by N—H...O and O—H...O hydrogen bonds into well‐separated two‐dimensional layers of about 15 Å thickness. The crescent conformation of the molecules is stabilized by weak intramolecular C—H...O and C—H...F hydrogen bonds. The uridine moiety adopts an anti conformation. The ribofuranose ring exists in an envelope conformation. All the endocyclic uracil bonds are shorter than normal single C—N and C—C bonds, and five of them have comparable lengths, which implies a considerable degree of delocalization of the electron density within this ring.     

(8RS)‐4‐Amino‐6‐(4‐chlorophenyl)‐8‐(2,4‐dichlorothiazol‐5‐yl)‐8,9‐dihydro‐7H‐pyrimido[4,5‐b][1,4]diazepine N,N‐dimethylformamide monosolvate: sheets built from N—H...N and C—H...O hydrogen bonds

In the title compound, C₁₆H₁₁Cl₃N₆S·C₃H₇NO, the seven‐membered ring adopts a conformation which is close to the twist‐boat form. The molecular components are linked into sheets by a combination of two N—H...N hydrogen bonds and two C—H...O hydrogen bonds. Comparisons are made with other aminopyrimidine derivatives.     

(E)‐2‐[2‐(1‐Naphthyl)­vinyl]‐3‐tosyl‐2,3‐di­hydro‐1,3‐benzo­thia­zole

The title compound, C₂₆H₂₁NO₂S₂, which consists of a benzo­thia­zole skeleton with α‐naphthyl­vinyl and tosyl groups at positions 2 and 3, respectively, was prepared by palladium–copper‐catalyzed heteroannulation. The E configuration of the mol­ecule about the vinyl C=C bond is established by the benzothiazole–naphthyl C—C—C—C torsion angle of 177.5 (4)°. The five‐membered heterocyclic ring adopts an envelope conformation with the Csp³ atom 0.380 (6) Å from the C₂NS plane. The two S—C [1.751 (4) and 1.838 (4) Å] and two N—C [1.426 (5) and 1.482 (5) Å] bond lengths in the thia­zole ring differ significantly.     

3‐Bromo­methyl‐3‐ethyl‐3,4,6,7,8,8a‐hexa­hydro‐1H‐pyrrolo­[2,1‐c][1,4]­oxazine‐1,4‐dione

In the title compound, C₁₀H₁₄BrNO₃, the six‐membered lactone ring is in a boat conformation, with the two carbonyl groups cis to one another across the boat basal plane. C—H⋯O hydrogen bonds and weak C—H⋯Br interactions stabilize the crystal structure.     

3β‐(1‐Allyl‐1‐pyrrolidinio)‐16‐(2‐pyridylmethylene)androst‐5‐en‐17β‐ol bromide hemihydrate

The title compound, C₃₂H₄₅N₂O⁺·Br^?·0.5H₂O, has the outer two six‐membered rings in chair conformations, while the central ring is in an 8β,9α‐half‐chair conformation. The five‐mem­bered ring of the steroid nucleus adopts a slightly deformed 14α‐envelope conformation. The pyridyl­methyl­ene moiety has an E configuration with respect to the hydroxyl group at position 17. The structure is stabilized by a network of O—H?Br‐type intermolecular hydrogen bonds.     

(S)‐trans‐Cyclohexane‐1,2‐dicarboximide

The molecule of the title compound, C₈H₁₁NO₂, contains a strained bicyclic system with a significantly twisted imide chromophore. The five‐membered ring fragment containing the imide function is strongly puckered and adopts a half‐chair conformation. The six‐membered ring has a slightly distorted chair conformation. The mol­ecules are joined by strong N—H?O and weak C—H?O hydrogen bonds into infinite chains.     

2′‐Amino‐3‐methoxy­pyrimidino­[5′,4′:16,17]­estra‐1,3,5(10),16‐tetraene

In the title compound, C₂₁H₂₅N₃O, the six‐membered ring that is fused to two other six‐membered rings in the estrane moiety adopts an envelope conformation. The compound shows intermolecular hydrogen bonding of the amine group to an N atom of the pyrimidine moiety, as well as weak intermolecular interactions involving H atoms in the hydro­phobic residue of the mol­ecule.     

16‐[3‐Methoxy‐4‐(2‐piperidin‐1‐yl­ethoxy)­benzyl­idene]‐17‐oxoandrost‐5‐en‐3β‐yl acetate monohydrate

The title compound, C₃₆H₄₉NO₅·H₂O, has the outer two six‐membered rings of the steroid nucleus in chair conformations. The central ring B of the steroid nucleus is in an 8β,9α‐half‐chair conformation, while ring D of the steroid adopts a slightly distorted 13β,14α‐half‐chair conformation. The piperidine ring is in a chair conformation. The methoxy­benzyl­idene moiety has an E configuration with respect to the carbonyl group at position 17. Intermolecular O—H?O and O—H?N hydrogen bonds link the steroid and water mol­ecules into chains which run parallel to the b axis.     

(5RS)‐6H‐Spiro[pyrazolo[1,5‐c]quinazoline‐5,4′‐thiochroman]: efficient synthesis under mild conditions,molecular structure and supramolecular assembly

Pyrazolo[1,5‐c]quinazolines are fused‐quinazoline derivatives which have been reported as potential agents against neurological disorders. The normal synthesis routes to these compounds require harsh reaction conditions, long reaction times or multistep sequences. The title compound, C₁₈H₁₅N₃S, has been prepared under very mild conditions by condensation of thiochroman‐4‐one with 5‐(2‐aminophenyl)‐1H‐pyrazole, which had itself been prepared by the reaction of hydrazine hydrate with 4‐hydroxyquinoline mediated by a brief period of microwave heating. Within the molecule in the crystal structure, the reduced pyrimidine ring adopts an envelope conformation, whereas the thiane ring adopts a half‐chair conformation. Molecules are linked into sheets by a combination of one N—H...S hydrogen bond and two independent C—H...π(arene) hydrogen bonds, which utilize the same aryl ring as the acceptor, with one C—H bond donating to each face of the ring. Comparisons are made with some related compounds.     

5‐Ethyl‐2′‐deoxy‐4′‐thiouridine (R)‐S‐oxide monohydrate

The pyrimidine ring of the title compound, C₁₁H₁₆N₂O₅S·H₂O, is planar to within 0.026 (1) Å and makes an angle of 77.73 (8)° with the mean plane of the thiosugar ring. In terms of standard nucleoside nomenclature, this ring has a C1′‐exo,C2′‐endo conformation. The O5′—C5′—C4′—C3′ torsion angle is ?167.4 (2)° and the glycosidic S4′—C1′—N1—C2 torsion angle is ?101.8 (2)° (anti).